Markets:

Overview

News

Currencies

International

Treasuries

Personalis, Inc. - Common Stock (NQ:PSNL)

6.340 -0.980 (-13.39%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption

March 17, 2026

From Personalis, Inc.

Via Business Wire

Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal®

March 12, 2026

From Personalis, Inc.

Via Business Wire

Lightspeed Makes a Big Bet on Self-Driving Trucks, Loading Up on 7 Million Shares of Kodiak AI (KDK) ↗

March 01, 2026

Specializing in AI-driven autonomy for commercial and defense vehicles, Kodiak AI targets clients seeking advanced navigation solutions.

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

Personalis Inc (NASDAQ:PSNL) Reports Mixed Q4 2025 Results and Aggressive 2026 Growth Outlook ↗

February 26, 2026

Via Chartmill

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Lightspeed Management Made a Huge Bet on Navan (NAVN) With a Purchase of 49.9 Million Shares ↗

March 01, 2026

Navan delivers AI-powered travel and expense management solutions for enterprise clients in the business software sector.

Via The Motley Fool

Topics Regulatory Compliance

Personalis (PSNL) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Personalis (PSNL) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Wondering what's happening in today's after-hours session? ↗

February 26, 2026

Via Chartmill

Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights

February 26, 2026

From Personalis, Inc.

Via Business Wire

Personalis to Participate in the TD Cowen 46th Annual Healthcare Conference

February 17, 2026

From Personalis, Inc.

Via Business Wire

Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results

February 12, 2026

From Personalis, Inc.

Via Business Wire

Top movers in Tuesday's pre-market session ↗

February 10, 2026

Via Chartmill

Why Personalis Stock Is Rising: Medicare Covers Lung Cancer MRD Test ↗

February 10, 2026

Medicare will reimburse the company’s NeXT Personal molecular residual disease (MRD) test when used to monitor patients with early to mid-stage non-small cell lung cancer (NSCLC).

Via Stocktwits

Topics Artificial Intelligence

Personalis Receives Medicare Coverage for NeXT Personal® in Lung Cancer Surveillance

February 10, 2026

From Personalis, Inc.

Via Business Wire

AIGH Capital Dumps 2.6 Million Lumen Technologies Shares In $15.6 Million Exit ↗

February 03, 2026

This telecom provider delivers fiber, cloud, and security services to businesses and consumers across U.S. and international markets.

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

AIGH Capital Dumps 1.1 Million MaxLinear (MXL) Shares ↗

February 02, 2026

This semiconductor company provides integrated RF and mixed-signal solutions for broadband, wireless, and industrial connectivity.

Via The Motley Fool

Personalis Announces New Publication Expanding Evidence for Ultrasensitive ctDNA Monitoring of Cancer Immunotherapy Response Across Solid Tumors

February 02, 2026

From Personalis, Inc.

Via Business Wire

Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

January 28, 2026

From Personalis, Inc.

Via Business Wire

Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™

January 12, 2026

From Personalis, Inc.

Via Business Wire

Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights

January 08, 2026

From Personalis, Inc.

Via Business Wire

Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors

December 17, 2025

From Personalis, Inc.

Via Business Wire

New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer

December 11, 2025

From Personalis, Inc.

Via Business Wire

Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 18, 2025

From Personalis, Inc.

Via Business Wire

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 10, 2025

In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday ↗

November 10, 2025

Via Benzinga

Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer

November 10, 2025

From Personalis, Inc.

Via Business Wire

What's going on in today's after hours session ↗

November 04, 2025

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

Personalis Reports Third Quarter 2025 Financial Results

November 04, 2025

From Personalis, Inc.

Via Business Wire

Personalis to Announce Third Quarter 2025 Financial Results

October 21, 2025

From Personalis, Inc.

Via Business Wire

Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing

October 16, 2025

From Personalis, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.